Surgery and risk for multiple sclerosis: A systematic review and meta-analysis of case-control studies

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Lunny, Carole ^a   Knopp Sihota, Jennifer A ^a   Fraser, Shawn N ^a  

^a ATHABASCA UNIVERSITY   (Canada)

Author keywords

Adenoidectomy; Appendectomy; Multiple sclerosis; Observational studies; Risk; Surgery; Systematic review; Tonsillectomy

Indexed keywords

ADENOIDECTOMY; APPENDECTOMY; ARTICLE; DISEASE ASSOCIATION; HEALTH HAZARD; HUMAN; META ANALYSIS; MULTIPLE SCLEROSIS; OBSERVATIONAL STUDY; SCORING SYSTEM; SYSTEMATIC REVIEW; TONSILLECTOMY;

CASE-CONTROL STUDIES; DATABASES, FACTUAL; HUMANS; MULTIPLE SCLEROSIS; RISK FACTORS;

EID: 84877054850     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-41     Document Type: Article

References (119)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2002, 359(9313):1221-1231. 10.1016/S0140-6736(02)08220-X, 11955556.
2. Whetten-Goldstein K, Sloan FA, Goldstein LB, Kulas ED. A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler 1998, 4(5):419-425.
3. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13(3):227-231. 10.1002/ana.410130302, 6847134.
4. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50(1):121-127. 10.1002/ana.1032, 11456302.
5. Banwell B, Bar-Or A, Arnold DL, Sadovnick D, Narayanan S, McGowan M, O'Mahony J, Magalhaes S, Hanwell H, Vieth R, Tellier R, Vincent T, Disanto G, Ebers G, Wambera K, Connolly MB, Yager J, Mah JK, Booth F, Sebire G, Callen D, Meaney B, Dilenge M-E, Lortie A, Pohl D, Doja A, Venketaswaran S, Levin S, MacDonald EA, Meek D, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 2011, 10(5):436-445. 10.1016/S1474-4422(11)70045-X, 21459044.
6. Handel AE, Handunnetthi L, Giovannoni G, Ebers GC, Ramagopalan SV. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol 2010, 17(9):1210-1214. 10.1111/j.1468-1331.2010.03003.x, 20345929.
7. Tselis A. Epstein-Barr virus cause of multiple sclerosis. Curr Opin Rheumatol 2012, 24(4):424-428. 410.1097/BOR.1090b1013e3283542cf3283548, 10.1097/BOR.0b013e3283542cf8, 22617821.
8. Disanto G, Morahan J, Ramagopalan S. Multiple sclerosis: risk factors and their interactions. CNS Neurol Disord Drug Targets 2012, 11(5):545-555. 10.2174/187152712801661266, 22583442.
9. Simpson S, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011, 82(10):1132-1141. 10.1136/jnnp.2011.240432, 21478203.
10. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007, 61(4):288-299. 10.1002/ana.21117, 17444504.
11. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] 2009, Higgins J, Green S.
12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012. 10.1001/jama.283.15.2008, 10789670.
13. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses [http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm].
14. Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 2006, 59(3):499-503. 10.1002/ana.20820, 16502434.
15. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analysis. Cochrane Handbook for Systematic Reviews of Interventions Version 510 (updated March 2011) 2011, The Cochrane Collaboration, Higgins J, Green S.
16. Ernst E, Pittler MH. Re-analysis of previous meta-analysis of clinical trials of homeopathy. J Clin Epidemiol 2000, 53(11):1188. 10.1016/S0895-4356(99)00226-7, 11186614.
17. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006, 295(6):676-680. 10.1001/jama.295.6.676, 16467236.
18. Review Manager (RevMan) [Computer program] 2011, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 51, Review Manager (RevMan) [Computer program].
19. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH. Chapter 12: Interpreting results and drawing conclusions. Cochrane Handbook for Systematic Reviews of Interventions Version 501 2008, The Cochrane Collaboration, Higgins J, Green S.
20. Becker H, Chochon F, de Toffol B, Defebvre L, Leger JM, Pierrot-Deseilligny C, Sellal F. [Report of the 55th meeting of the American Academy of Neurology. Honolulu, March 29-April 6, 2003]. Rev Neurol (Paris) 2003, 159(4):470-486.
21. De Portugal AJ, Fereres JS. [Considerations on the relationship of injury and multiple sclerosis]. Med Clin (Barc) 1965, 44(4):252-255.
22. Goncharova ZA, Baliazin VA. [Risk factors of multiple sclerosis development in the population of the Rostov region]. Zh Nevrol Psikhiatr Im S S Korsakova 2009, 109(7 Suppl 2):10-15.
23. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands and the lack of protection by exposure in infancy. Neuroepidemiology 1992, 11(2):90-99. 10.1159/000110917, 1495579.
24. Levine NS, Atkins A, McKeel DW, Peck SD, Pruitt BA. Spinal cord injury following electrical accidents: case reports. J Trauma 1975, 15(5):459-463. 10.1097/00005373-197505000-00015, 1127774.
25. Popescu D, Popescu VG. [Risk factors in multiple sclerosis: epidemiological studies in the Arges region]. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir 1981, 26(1):23-31.
26. Beziehungen W. Zwischen erkrankkungen ins Kindesalter und multiple-sklerose-erkrankung. Schweiz Arch Neurol Neurchir Psychiatr 1970, 106(2):311-317.
27. Delilović-Vranić J, Tiric-Campara M, Subasic N. Newly discovered MS cases. 12th Congress of the European Federation of Neurological Societies. 2008 Annual Meeting 2008, August 23-26.
28. Beltran I, Molto-Jorda JM, Diaz-Marin C, Martin R, Matias-Guiu J. [Analytical epidemiological study of multiple sclerosis in Alcoi]. Rev Neurol 1998, 26(149):67-69.
29. Benedikz J, Magnusson H, Guthmundsson G. Multiple sclerosis in Iceland, with observations on the alleged epidemic in the Faroe Islands. Ann Neurol 1994, 36(Suppl 2):S175-179.
30. Boiko A, Deomina T, Favorova O, Gusev E, Sudomoina M, Turetskaya R. Epidemiology of multiple sclerosis in Russia and other countries of the former Soviet Union: investigations of environmental and genetic factors. Acta Neurol Scand Suppl 1995, 161:71-76.
31. Di Legge S, Piattella MC, Pozzilli C, Pantano P, Caramia F, Pestalozza IF, Paolillo A, Lenzi GL. Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis. Mult Scler 2003, 9(3):302-306. 10.1191/1352458503ms921oa, 12814180.
32. Frutos Alegria MT, Beltran-Blasco I, Quilez-Iborra C, Molto-Jorda J, Diaz-Marin C, Matias-Guiu J. [The epidemiology of multiples sclerosis in Alcoi. Analytical data]. Rev Neurol 2002, 34(9):813-816.
33. Gusev EI, Boiko AN, Demina TL, Sudomoina MA, Alekseev AP, Boldyreva MN, Trofimov D, Favorova OO. [The risk factors for the development of multiple sclerosis in the Moscow population. II. The combination of exogenous and hereditary factors]. Zh Nevrol Psikhiatr Im S S Korsakova 1999, 99(6):47-52.
34. Gusev EI, Boiko AN, Smirnova NF, Demina TL. [Risk factors of multiple sclerosis in Moscow population. I. Exogenous risk factors]. Zh Nevrol Psikhiatr Im S S Korsakova 1999, 99(5):32-40.
35. Gusev EI, Zavalishin IA, Boiko AN, Khoroshilova NL, Iakovlev AP. [Epidemiological characteristics of multiple sclerosis in Russia]. Zh Nevrol Psikhiatr Im S S Korsakova 2002, Suppl:3-6.
36. Kahana E, Zilber N, Abramson JH, Biton V, Leibowitz Y, Abramsky O. Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated. J Neurol 1994, 241(5):341-346. 10.1007/BF00868444, 8006689.
37. Karnaukh VN. [Epidemiology of multiple sclerosis in Amur region]. Zh Nevrol Psikhiatr Im S S Korsakova 2009, 109(8):59-62.
38. Li J, Johansen C, Bronnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J. The risk of multiple sclerosis in bereaved parents: a nationwide cohort study in Denmark. Neurology 2004, 62(5):726-729. 10.1212/01.WNL.0000113766.21896.B1, 15007121.
39. Meurman L, Wising P. [Multiple sclerosis, tonsillectomy, and herpes zoster varicellosus]. Lakartidningen 1966, 63(14):1318-1319.
40. Poser CM. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect. Clin Neurol Neurosurg 2006, 108(3):227-233. 10.1016/j.clineuro.2005.11.019, 16406307.
41. Souberbielle BE, Martin-Mondiere C, O'Brien ME, Carydakis C, Cesaro P, Degos JD. A case-control epidemiological study of MS in the Paris area with particular reference to past disease history and profession. Acta Neurol Scand 1990, 82(5):303-310.
42. Spitzer C, Bouchain M, Winkler LY, Wingenfeld K, Gold SM, Grabe HJ, Barnow S, Otte C, Heesen C. Childhood trauma in multiple sclerosis: a case-control study. Psychosom Med 2012, 74(3):312-318. 10.1097/PSY.0b013e31824c2013, 22408134.
43. Warren S, Cockerill R, Warren KG. Risk factors by onset age in multiple sclerosis. Neuroepidemiology 1991, 10(1):9-17. 10.1159/000110241, 2062417.
44. Weilbach FX, Hartung HP. [Physical trauma and multiple sclerosis]. Nervenarzt 1997, 68(12):940-944. 10.1007/s001150050220, 9465335.
45. Bangsi D, Ghadirian P, Ducic S, Morisset R, Ciccocioppo S, McMullen E, Krewski D. Dental amalgam and multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 1998, 27(4):667-671. 10.1093/ije/27.4.667, 9758123.
46. Adams DK, Sutherland JM, Fletcher WB. Early clinical manifestations of disseminated sclerosis. BMJ 1950, 2(4676):431-436. 10.1136/bmj.2.4676.431, 2038608, 15434411.
47. Hollander E. Trauma, multiple sclerosis, delayed sleep phase disorder, subjective experiences, and duration of illness in GAD. CNS Spectr 2008, 13(5):361-362.
48. Horton AM, Siegel E. Comparison of multiple sclerosis and head trauma patients: a neuropsychological pilot study. Int J Neurosci 1990, 53(2-4):213-215.
49. Mutlu N. Multiple sclerosis in Turkey; etiologic and symptomatologic study of four hundred ten cases. AMA Arch Neurol Psychiatry 1954, 71(4):511-516. 10.1001/archneurpsyc.1954.02320400107011, 13147609.
50. Selcen D, Anlar B, Renda Y. Multiple sclerosis in childhood: report of 16 cases. Eur Neurol 1996, 36(2):79-84. 10.1159/000117213, 8654490.
51. Stazio A, Paddison RM, Kurland LT. Multiple sclerosis in New Orleans, Louisiana, and Winnipeg, Manitoba, Canada: follow-up of a previous survey in New Orleans, and comparison between the patient populations in the two communities. J Chronic Dis 1967, 20(5):311-332. 10.1016/0021-9681(67)90059-8, 6026359.
52. Kranz JM, Kurland LT, Schuman LM, Layton D. Multiple sclerosis in Olmsted and Mower counties, Minnesota. Neuroepidemiology 1983, 2(3-4):106-118.
53. Lauer K. Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies. Acta Neurol Scand Suppl 1995, 161:77-88.
54. Lauer K, Firnhaber W. Prognostic criteria in an epidemiological group of patients with multiple sclerosis: an exploratory study. J Neurol 1992, 239(2):93-97. 10.1007/BF00862981, 1552310.
55. Mellor A. Case-control study to collect medical and epidemiological data and blood samples for research into the causes of multiple sclerosis and selected demyelinating diseases. 2006, 1-18. Waltham, MA: Accelerated Cure Project for MS.
56. Visscher BR, Clark VA, Detels R, Malmgren RM, Valdiviezo NL, Dudley JP. Two populations with multiple sclerosis. Clinical and demographic characteristics. J Neurol 1981, 225(4):237-249. 10.1007/BF00313296, 6169803.
57. Alonso A, Hernan MA, Ascherio A. Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis. Acta Neurol Scand 2008, 117(1):15-20.
58. Antonovsky A, Leibowitz U, Medalie JM, Smith HA, Halpern L, Alter M. Reappraisal of possible etiologic factors in multiple sclerosis. Am J Public Health Nations Health 1968, 58(5):836-848. 10.2105/AJPH.58.5.836, 1228494, 5689628.
59. Brain R, Wilkinson M. The association of cervical spondylosis and disseminated sclerosis. Brain 1957, 80(4):456-478. 10.1093/brain/80.4.456, 13499755.
60. Conradi S, Malzahn U, Schroter F, Paul F, Quill S, Spruth E, Harms L, Then Bergh F, Ditzenbach A, Georgi T, Heuschmann P, Rosche B. Environmental factors in early childhood are associated with multiple sclerosis: a case-control study. BMC Neurol 2011, 11:123. 10.1186/1471-2377-11-123, 3203040, 21978074.
61. The Coordinating Center and the Neurological Centers of the Cooperative Group Cooperative Italian study on multiple sclerosis and risk factors: a case-control study. Ital J Neurol Sci 1987, Suppl 6:17-20. The Coordinating Center and the Neurological Centers of the Cooperative Group.
62. Alonso A, Cook SD, Maghzi AH, Divani AA. A case-control study of risk factors for multiple sclerosis in Iran. Mult Scler 2011, 17(5):550-555. 10.1177/1352458510397685, 21325015.
63. Alter M, Speer J. Clinical evaluation of possible etiologic factors in multiple sclerosis. Neurology 1968, 18(2):109-116. 10.1212/WNL.18.2.109, 5688752.
64. Andersen E, Isager H, Hyllested K. Risk factors in multiple sclerosis: tuberculin reactivity, age at measles infection, tonsillectomy and appendectomy. Acta Neurol Scand 1981, 63(2):131-135.
65. Antonovsky A, Leibowitz U, Smith HA, Medalie JM, Balogh M, Kats R, Halpern L, Alter M. Epidemiologic study of multiple sclerosis in Israel. An overall review of methods and findings. Arch Neurol 1965, 13:183-193. 10.1001/archneur.1965.00470020073010, 14315670.
66. Bansil S, Singhal BS, Ahuja GK, Riise T, Ladiwala U, Behari M, Cook SD. Multiple sclerosis in India: a case-control study of environmental exposures. Acta Neurol Scand 1997, 95(2):90-95. 10.1111/j.1600-0404.1997.tb00075.x, 9059727.
67. Berr C, Puel J, Clanet M, Ruidavets JB, Mas JL, Alperovitch A. Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrenees, France. Acta Neurol Scand 1989, 80(1):46-50. 10.1111/j.1600-0404.1989.tb03841.x, 2782041.
68. Bobowick AR, Kurtzke JF, Brody JA, Hrubec Z, Gillespie M. Twin study of multiple sclerosis: an epidemiologic inquiry. Neurology 1978, 28(10):978-987. 10.1212/WNL.28.10.978, 570667.
69. Broadley SA, Deans J, Chataway SJ, Sawcer SJ, Compston DA. Multiple sclerosis and tonsillectomy: no evidence for an influence on the development of disease or clinical phenotype. Mult Scler 2000, 6(2):121-123.
70. Casetta I, Granieri E, Malagu S, Tola MR, Paolino E, Caniatti LM, Govoni V, Monetti VC, Fainardi E. Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology 1994, 13(3):120-128. 10.1159/000110369, 8015665.
71. Cendrowski W, Wender M, Dominik W, Flejsierowicz Z, Owsianowski M, Popiel M. Epidemiological study of multiple sclerosis in western Poland. Eur Neurol 1969, 2(2):90-108. 10.1159/000113777, 5819891.
72. Currier RD, Eldridge R. Possible risk factors in multiple sclerosis as found in a national twin study. Arch Neurol 1982, 39(3):140-144. 10.1001/archneur.1982.00510150010003, 7199899.
73. Currier RD, Martin EA, Woosley PC. Prior events in multiple sclerosis. Neurology 1974, 24(8):748-754. 10.1212/WNL.24.8.748, 4858420.
74. da Silva KR, Alvarenga RM, Fernandez YFO, Alvarenga H, Thuler LC. Potential risk factors for multiple sclerosis in Rio de Janeiro: a case-control study. Arq Neuropsiquiatr 2009, 67(2A):229-234.
75. De Gennaro RE, Ragazzi M, Caniatti E, Cesnik P, Fazio V, Simioni V, Govoni I, Casetta E, Granieri E. Environmental risk factors in multiple sclerosis. Different exposure in 3 genetically distinct populations with analytical approach 2009, Padova, Palazzo della Fiera: XL Congresso Società Italiana di Neurologia.
76. Dokuchaeva NN, Boiko AN. [Clinical and epidemiological study of multiple sclerosis in Volgograd city]. Zh Nevrol Psikhiatr Im S S Korsakova 2006, Spec No 3:4-10.
77. Dolan R. Epidemiological Review of the Cluster of Multiple Sclerosis within East Boston and Winthrop, MA: Possible Roles of Childhood Nutrition and Xenobiotics Exposure as Causative Factors for the Disease http://www.areco.org/ms.pdf; 2003.
78. Gronning M, Riise T, Kvale G, Albrektsen G, Midgard R, Nyland H. Infections in childhood and adolescence in multiple sclerosis. A case-control study. Neuroepidemiology 1993, 12(2):61-69. 10.1159/000110302, 8232705.
79. Gusev E, Boiko A, Lauer K, Riise T, Deomina T. Environmental risk factors in MS: a case-control study in Moscow. Acta Neurol Scand 1996, 94(6):386-394.
80. Hopkins RS, Indian RW, Pinnow E, Conomy J. Multiple sclerosis in Galion, Ohio: prevalence and results of a case-control study. Neuroepidemiology 1991, 10(4):192-199. 10.1159/000110269, 1745329.
81. Koch MJ, Reed D, Stern R, Brody JA. Multiple sclerosis. A cluster in a small Northwestern United States community. JAMA 1974, 228(12):1555-1557. 10.1001/jama.1974.03230370037020, 4406706.
82. Koch-Henriksen N. An epidemiological study of multiple sclerosis. Familial aggregation social determinants, and exogenic factors. Acta Neurol Scand Suppl 1989, 124:1-123.
83. Kurtzke JF, Hyllested K, Arbuckle JD, Bronnum-Hansen H, Wallin MT, Heltberg A, Jacobsen H, Olsen A, Eriksen LS. Multiple sclerosis in the Faroe Islands. Results of a case control questionnaire with multiple controls. Acta Neurol Scand 1997, 96(3):149-157.
84. Lamoureux G, Giard N, Jolicoeur R, Toughlian V, Desrosiers M. Immunological features in multiple sclerosis. BMJ 1976, 1(6003):183-186. 10.1136/bmj.1.6003.183, 1638425, 764920.
85. Lauer K, Firnhaber W. Descriptive and analytical epidemiological data on multiple sclerosis from a long-term study in southern Hesse, Germany. Multiple Sclerosis in Europe: An Epidemiological Update. edn 1994, 147-158. Darmstadt: LTV Press, Firnhaber W, Lauer K.
86. Martinez Sobrepera HJ, Cabrera Gomez JA, Tuero Iglesias A. [Exogenous factors in the aetiology of multiple sclerosis in Cuba. A study of cases and controls]. Rev Neurol 2001, 33(10):931-937.
87. Poskanzer DC. Tonsillectomy and multiple sclerosis. Lancet 1965, 2(7425):1264-1266.
88. Poskanzer DC, Sheridan JL, Prenney LB, Walker AM. Multiple sclerosis in the Orkney and Shetland Islands. II: the search for an exogenous aetiology. J Epidemiol Comm Health 1980, 34(4):240-252.
89. Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery SM. Appendicectomy and multiple sclerosis risk. Eur J Neurol 2011, 18(4):667-669. 10.1111/j.1468-1331.2010.03147.x, 20629715.
90. Westlund KB, Kurland LT. Studies on multiple sclerosis in Winnepeg, Manitoba, and New Orleans, Louisiana. I. Prevalence; comparison between the patient groups in Winnipeg and New Orleans. Am J Hyg 1953, 57(3):380-396.
91. YosefiPour G, Rasekhi A. Multiple sclerosis: a risk factor analysis in Iran. Arch Iran Med 2002, 5(3):191-193.
92. Zaadstra BM, Chorus AM, van Buuren S, Kalsbeek H, van Noort JM. Selective association of multiple sclerosis with infectious mononucleosis. Mult Scler 2008, 14(3):307-313. 10.1177/1352458507084265, 18208871.
93. Zilber N, Kahana E. Risk factors for multiple sclerosis: a case-control study in Israel. Acta Neurol Scand 1996, 94(6):395-403. 10.1111/j.1600-0404.1996.tb00051.x, 9017027.
94. Zorzon M, Zivadinov R, Nasuelli D, Dolfini P, Bosco A, Bratina A, Tommasi MA, Locatelli L, Cazzato G. Risk factors of multiple sclerosis: a case-control study. Neurological Sciences 2003, 24(4):242-247. 10.1007/s10072-003-0147-6, 14658040.
95. Siva A, Radhakrishnan K, Kurland LT, O'Brien PC, Swanson JW, Rodriguez M. Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology 1993, 43(10):1878-1882. 10.1212/WNL.43.10.1878, 8413941.
96. Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. Cochrane Handbook for Systematic Reviews of Interventions Version 510 (updated March 2011) 2011, The Cochrane Collaboration, Higgins JPT, Green S.
97. Paffenbarger RS. The effect of prior tonsillectomy on incidence and clinical type of acute poliomyelitis. Am J Hyg 1957, 66(2):131-150.
98. Paffenbarger RS, Wilson VO. Previous tonsillectomy and current pregnancy as they affect risk of poliomyelitis attack. Ann N Y Acad Sci 1955, 61(4):856-868. 10.1111/j.1749-6632.1955.tb42543.x, 13340593.
99. Siegel M, Greenberg M, Magee MC. Tonsillectomy and poliomyelitis. II. Frequency of bulbar paralysis, 1944-1949. J Pediatr 1951, 38(5):548-558. 10.1016/S0022-3476(51)80296-8, 14832710.
100. Yamanaka N, Kataura A. Viral infections associated with recurrent tonsillitis. Acta Otolaryngol Suppl 1984, 416:30-37.
101. Lucas RM, Hughes AM, Lay M-LJ, Ponsonby A-L, Dwyer DE, Taylor BV, Pender MP. Epstein-Barr virus and multiple sclerosis. J Neurol Neurosurg Psychiatry 2011, 82(10):1142-1148. 10.1136/jnnp-2011-300174, 21836034.
102. Bagos PG, Nikolopoulos G, Ioannidis A. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 2006, 12(4):397-411. 10.1191/1352458506ms1291oa, 16900753.
103. Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC. Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand Suppl 1995, 161:34-42.
104. Krone B, Oeffner F, Grange JM. Is the risk of multiple sclerosis related to the 'biography' of the immune system?. J Neurol 2009, 256(7):1052-1060. 10.1007/s00415-009-5068-8, 2708340, 19252771.
105. Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain 2008, 131(Pt 7):1712-1721.
106. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005, 293(20):2496-2500. 10.1001/jama.293.20.2496, 15914750.
107. Randal Bollinger R, Barbas AS, Bush EL, Lin SS, Parker W. Biofilms in the large bowel suggest an apparent function of the human vermiform appendix. J Theor Biol 2007, 249(4):826-831. 10.1016/j.jtbi.2007.08.032, 17936308.
108. Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F. B cells and multiple sclerosis. Lancet Neurol 2008, 7(9):852-858. 10.1016/S1474-4422(08)70192-3, 18703007.
109. Correale J, Farez MF. The impact of environmental infections (parasites) on MS activity. Mult Scler 2011, 17(10):1162-1169. 10.1177/1352458511418027, 21980148.
110. Norgaard M, Nielsen RB, Jacobsen JB, Gradus JL, Stenager E, Koch-Henriksen N, Lash TL, Sorensen HT. Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study. Am J Epidemiol 2011, 174(8):945-948. 10.1093/aje/kwr201, 21920946.
111. Alder AC, Fomby TB, Woodward WA, Haley RW, Sarosi G, Livingston EH. Association of viral infection and appendicitis. Arch Surg 2010, 145(1):63-71. 10.1001/archsurg.2009.250, 20083756.
112. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterol 2005, 129(3):827-836.
113. Matsushita M, Takakuwa H, Matsubayashi Y, Nishio A, Ikehara S, Okazaki K. Appendix is a priming site in the development of ulcerative colitis. World J Gastroenterol 2005, 11(31):4869-4874.
114. Pender MP. CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmune Dis 2012, 2012:189096. 3270541, 22312480.
115. Laurin M, Everett ML, Parker W. The cecal appendix: one more immune component with a function disturbed by post-industrial culture. Anat Rec (Hoboken) 2011, 294(4):567-579.
116. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001, 22(2):117-139. 10.1007/s100720170011, 11603614.
117. Livingston EH, Fomby TB, Woodward WA, Haley RW. Epidemiological similarities between appendicitis and diverticulitis suggesting a common underlying pathogenesis. Arch Surg 2011, 146(3):308-314. 10.1001/archsurg.2011.2, 21422362.
118. Fleming JO, Carrithers MD. Diagnosis and management of multiple sclerosis: a handful of patience. Neurol 2010, 74(11):876-877.
119. Krone B, Pohl D, Rostasy K, Kahler E, Brunner E, Oeffner F, Grange JM, Gartner J, Hanefeld F. Common infectious agents in multiple sclerosis: a case-control study in children. Mult Scler 2008, 14(1):136-139. 10.1177/1352458507082069, 17942525.